Open AccessP857: BORTEZOMIB‐ AND CARFILZOMIB‐RESISTANT MYELOMA CELLS SHOW INCREASED ACTIVITY OF ALL THREE ARMS OF UNFOLDED PROTEIN RESPONSE AND ENRICHMENT OF SIRTUIN SIGNALING PATHWAY
Author(s) -
Kubicki T.,
Bednarek K.,
KostrzewskaPoczekaj M.,
Łuczak M.,
Kanduła Z.,
Lewandowski K.,
Gil L.,
JarmużSzymczak M.,
Dytfeld D.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846308.64889.17
Subject(s) - carfilzomib , bortezomib , proteasome inhibitor , proteasome , cell culture , cancer research , chemistry , microbiology and biotechnology , biology , pharmacology , multiple myeloma , immunology , genetics